| Indication | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | NDA |
|---|---|---|---|---|---|
| Single Agent: Recurrent TMZ-resistant (MDACC) MGMT-unmethylated GBM |
Pre-clinical Phase complete
|
Phase 1 Phase complete
|
Phase 2 Phase in progress
|
Phase 3 Phase not started
|
NDA Phase not started
|
| Combination with XRT: Newly Diagnosed (Sun Yat-sen University) MGMT-unmethylated GBM |
Pre-clinical Phase complete
|
Phase 1 Phase complete
|
Phase 2 Phase in progress
|
Phase 3 Phase not started
|
NDA Phase not started
|
| Ovarian cancer |
Pre-clinical Phase in progress
|
Phase 1 Phase not started
|
Phase 2 Phase not started
|
Phase 3 Phase not started
|
NDA Phase not started
|
| Pediatric Brain Tumor |
Pre-clinical Phase in progress
|
Phase 1 Phase not started
|
Phase 2 Phase not started
|
Phase 3 Phase not started
|
NDA Phase not started
|